Detalhe da pesquisa
1.
CircPVT1 promotes ER-positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS.
EMBO J
; 42(10): e112408, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37009655
2.
Targeting the PHF8/YY1 axis suppresses cancer cell growth through modulation of ROS.
Proc Natl Acad Sci U S A
; 121(2): e2219352120, 2024 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38165927
3.
JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex.
Mol Cell
; 70(2): 340-357.e8, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29628309
4.
CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development.
Nucleic Acids Res
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38676947
5.
A deregulated m6A writer complex axis driven by BRD4 confers an epitranscriptomic vulnerability in combined DNA repair-targeted therapy.
Proc Natl Acad Sci U S A
; 120(41): e2304534120, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37782793
6.
LncRNA LUESCC promotes esophageal squamous cell carcinoma by targeting the miR-6785-5p/NRSN2 axis.
Cell Mol Life Sci
; 81(1): 121, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38457049
7.
lncRNA ITGB8-AS1 functions as a ceRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling.
Mol Ther
; 30(2): 688-702, 2022 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34371180
8.
Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axis.
Mol Cancer
; 21(1): 69, 2022 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35255921
9.
BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma.
Mol Ther
; 29(10): 3011-3026, 2021 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34058385
10.
JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner.
Nucleic Acids Res
; 45(6): 3503-3518, 2017 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27899633
11.
A CARM1 Inhibitor Potently Suppresses Breast Cancer Both In Vitro and In Vivo.
J Med Chem
; 67(10): 7921-7934, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713486
12.
MAVI1, an endoplasmic reticulum-localized microprotein, suppresses antiviral innate immune response by targeting MAVS on mitochondrion.
Sci Adv
; 9(35): eadg7053, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37656786
13.
Estrogen-Induced LncRNA, LINC02568, Promotes Estrogen Receptor-Positive Breast Cancer Development and Drug Resistance Through Both In Trans and In Cis Mechanisms.
Adv Sci (Weinh)
; 10(25): e2206663, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37404090
14.
ER-localized JmjC domain-containing protein JMJD8 targets STING to promote immune evasion and tumor growth in breast cancer.
Dev Cell
; 58(9): 760-778.e6, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37054705
15.
METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions.
Nat Commun
; 13(1): 6350, 2022 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36289222
16.
A Novel Meiosis-Related lncRNA, Rbakdn, Contributes to Spermatogenesis by Stabilizing Ptbp2.
Front Genet
; 12: 752495, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34707642
17.
Estrogen-induced circRNA, circPGR, functions as a ceRNA to promote estrogen receptor-positive breast cancer cell growth by regulating cell cycle-related genes.
Theranostics
; 11(4): 1732-1752, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33408778
18.
OTUD7B Deubiquitinates LSD1 to Govern Its Binding Partner Specificity, Homeostasis, and Breast Cancer Metastasis.
Adv Sci (Weinh)
; 8(15): e2004504, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050636
19.
Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition.
Cancer Immunol Res
; 9(6): 707-722, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33875483
20.
EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo.
Clin Transl Immunology
; 9(5): e01135, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32373345